Detection of circulating tumor cell sub-populations in patients with head and neck squamous cell carcinoma (HNSCC)

被引：0
|
作者：
Hassenkamp, P. [1 ]
Nel, I. [2 ]
Weller, P. [1 ]
Dountsop, P. [3 ]
Lehnerdt, G. [1 ]
Hoffmann, A. -C. [2 ]
机构：
[1] Univ Klinikum Essen, Univ Hals Nasen Ohrenklin, Essen, Germany
[2] Univ Klinikum Essen, Innere Klin Tumorforsch, Essen, Germany
[3] Evangel Krankenhaus, HNO Klin, Dusseldorf, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：77 / 78
页数：2
相关论文
共 50 条
  • [31] Circulating tumor DNA kinetics in recurrent/metastatic head & neck squamous cell cancer (R/M HNSCC) patients
    Taylor, K.
    Zou, J.
    Burgener, J.
    Zhao, E.
    Torti, D.
    Oliva, M.
    Spreafico, A.
    Hansen, A. R.
    Jang, R.
    McDade, S. S.
    Coyle, V. M.
    Lawler, M.
    Elimova, E.
    Bratman, S. V.
    Siu, L. L.
    ANNALS OF ONCOLOGY, 2021, 32 : S796 - S797
  • [32] CIRCULATING TUMOR CELLS (CTCS) IN PATIENTS WITH RECURRENT/METASTATIC HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC): FREQUENCY, CLINICAL SIGNIFICANCE AND EGFR EXPRESSION
    Grisanti, S.
    Almici, C.
    Consoli, F.
    Verardi, R.
    Buglione, M.
    Ferrari, V. D.
    Bolzoni-Villaret, A.
    Nicolai, P.
    Magrini, S. M.
    Simoncini, E.
    ANNALS OF ONCOLOGY, 2012, 23 : 338 - 338
  • [33] Histopathologic Determinants of Tumor-Immune Microenvironment in Head and Neck Squamous Cell Carcinoma (HNSCC)
    de la Iglesia, Janis
    Hernandez-Prera, Juan
    Masannat, Jude
    Wenig, Bruce
    Slebos, Robbert
    Chung, Christine
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1189 - 1189
  • [34] Histopathologic Determinants of Tumor-Immune Microenvironment in Head and Neck Squamous Cell Carcinoma (HNSCC)
    de la Iglesia, Janis
    Hernandez-Prera, Juan
    Masannat, Jude
    Wenig, Bruce
    Slebos, Robbert
    Chung, Christine
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1189 - 1189
  • [35] Circulating tumor cell analysis in locally advanced and metastatic squamous cell carcinoma of the head and neck
    Harris, Ethan J.
    Huang, Julian
    Carroll, Erin
    Lowe, Alarice C.
    Chau, Nicole G.
    Rabinowits, Guilherme
    Haddad, Robert
    Hanna, Glenn J.
    Haddad, Tyler
    Sanborn, Matthew
    Kacew, Alec
    Lorch, Jochen
    LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2020, 5 (06): : 1063 - 1069
  • [36] Novel Predictive Biomarkers in the Head and Neck Squamous Cell Carcinoma (HNSCC)
    Miniuk, Magdalena
    Reszec-Gielazyn, Joanna
    Bortnik, Piotr
    Borsukiewicz, Agata
    Mroczek, Aleksandra
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (19)
  • [37] Differential expression profiling of head and neck squamous cell carcinoma (HNSCC)
    F Lemaire
    R Millon
    J Young
    A Cromer
    C Wasylyk
    I Schultz
    D Muller
    P Marchal
    C Zhao
    D Melle
    L Bracco
    J Abecassis
    B Wasylyk
    British Journal of Cancer, 2003, 89 : 1940 - 1949
  • [38] LncRNAs as prognostic biomarkers in head and neck squamous cell carcinoma (HNSCC)
    Chaudhary, Ritu
    Wang, Xuefeng
    Cao, Biwei
    Gimbrone, Nicholas T.
    Slebos, Robbert J. C.
    Chung, Christine H.
    CANCER RESEARCH, 2019, 79 (13)
  • [39] Tumour stem cells in head and neck squamous cell carcinoma (HNSCC)
    Goldie, S. J.
    Watt, F. M.
    Price, R.
    ORAL ONCOLOGY, 2009, : 72 - 72
  • [40] Biomarkers of resistance to cetuximab in head and neck squamous cell carcinoma (HNSCC).
    Surikova, Ekaterina I.
    Kit, Oleg I.
    Neskubina, Irina V.
    Frantsiyants, Elena M.
    Vladimirova, Liubov Yu
    Lyanova, Aza A.
    Engibaryan, Marina A.
    Shalashnaya, Elena V.
    Aedinova, Irina V.
    Ulianova, Yulia V.
    Volkova, Viktoriya L.
    Pustovaya, Irina Viktorovna
    Ezhova, Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345